Clinical trial · Observational
The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer
NCT07590570CI-TRIAL-00111696active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicentre study to investigate the association of fingernail lunula status with the efficacy and safety of neoadjuvant therapy in breast cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Invasive | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| neoadjuvant therapy | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- retrospective
- description
- no requirements for therapy
- interventionNames
- Drug: neoadjuvant therapy
- label
- prospective
- description
- no requirements for therapy
- interventionNames
- Drug: neoadjuvant therapy
Primary outcomes (1)
- measure
- Pathological Complete Response (pCR) Rate
- timeFrame
- at surgery
- description
- ypT0 ypN0
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 18 years or older * Pathologically confirmed invasive primary breast cancer * Patients who have received or are scheduled to receive neoadjuvant therapy Exclusion Criteria: * De novo stage IV breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.